(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Lower Back Pain
If you are aged 18 to 65, have moderate-to-severe low back pain, and the current episode has lasted two days or less, you may qualify for this study.
The research site is in Denver, Colo.
More information
Please see http://www.centerwatch.com/patient/studies/cat700.html. 
-----
Neuroblastoma
This phase IIa trial is studying the side effects and best dose of Ultratrace iodine I 131 MIBG, followed by a stem cell transplant in treating young people with relapsed or refractory high-risk neuroblastoma.
The research site is in Madison, Wisc.
More information
Please see http://www.centerwatch.com/patient/studies/cat342.html.
-----
Diabetic Neuropathy
If you have type 1 or type 2 diabetes mellitus and a history of chronic pain attributable to a symmetrical stocking distribution neuropathy in the lower extremities, you may qualify for this study.
The research site is in Murrells Inlet, S.C.
More information
Please see http://www.centerwatch.com/patient/studies/cat253.html.
-----
Copyright 2008 CenterWatch. All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.